Syndax Pharmaceuticals · 13 hours ago
Systems of Care Director - Southeast
Atlanta, GA
Full-time
Onsite
Director/Executive
$250K/yr - $270K/yr
8+ years expSyndax Pharmaceuticals is a commercial stage biopharmaceutical company developing innovative cancer therapies. The Systems of Care Director will play a critical role in the Customer Engagement Team, focusing on embedding Syndax within influential healthcare systems across the United States and collaborating with key opinion leaders in Hematology/Oncology.
BiotechnologyClinical TrialsHealth CarePharmaceutical
Responsibilities
Work closely with multiple Syndax stakeholders inside and outside the commercial organization to ensure strategic alignment and execution of key strategies/tactics to advance overall business objectives
Partner with external HCP stakeholders at key healthcare systems across the US to ensure seamless access/availability to Syndax treatments post-FDA approval
Identify, profile, cultivate and maintain long-term relationships with KOLs within the Hematology/Oncology community
Plan and execute KOL engagements and executive encounters at local, regional, and national conferences; POAs; field visits, and other venues in a compliant manner
Identify and prioritize novel programming, venues, etc. where Syndax should invest to advance overall business objectives
Develop and foster an environment where the overall patient, caregiver, and HCP customer experience are prioritized
Become embedded in target healthcare systems by differentiating themselves from competitors through delivering consistent value
Adapt quickly to needs/adjustments necessitated by launch preparations and contribute to supporting both corporate and field-based colleagues in navigating a dynamic and evolving market to achieve and exceed expected results in a complex specialty environment
Partner cross-functionally with internal stakeholders to execute / pull-through business plans and serve as a critical member of the Customer Engagement team
Develop and maintain all account/contact details within CRM
Ensure budgets and schedules meet corporate requirements
Incorporate all appropriate regulatory and legal compliance into daily activities and business practices
Qualification
Required
BA/BS or healthcare equivalent degree required
Minimum 8+ years of previous pharmaceutical, biotech, and/or medical experience with a strong knowledge of the pharmaceutical marketplace and deep understanding of industry and broader trends in the healthcare landscape
Minimum of 5+ years combined experience in specialty and/or rare disease (Hematology/Oncology preferred)
Proven ability to access and influence C/D-Suite level customers
Collaborative and organizationally savvy team player with a history of success in a matrixed setting
Strong negotiation, partnering, and influencing skills; demonstrated ability to effectively manage business relationships with external strategic partners
Prior experience working in large accounts and/or hospitals required. Expert at navigating complexities and removing barriers to advance corporate objectives in service of patients, caregivers, and HCPs
Successful product launch experience required
Technologically savvy and committed to leveraging data and advanced analytics daily to drive business results
Ability to travel on a frequent overnight basis, with occasional weekend travel, depending on business needs
Must possess a valid driver's license and have reliable access to a personal vehicle for travel as required by the role
Preferred
Prior pharma/biotech start-up experience preferred
Benefits
Equity offering
Annual target bonuses
Outstanding benefits program
Company
Syndax Pharmaceuticals
Syndax Pharmaceuticals focuses on developing an HDAC inhibitor for solid tumors and hematological tumors.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.1BKey Investors
Royalty Pharma
2024-11-04Post Ipo Debt· $350M
2023-12-14Post Ipo Equity· $230M
2022-12-06Post Ipo Equity· $150M
Leadership Team
Michael Metzger
Chief Executive Officer and Director
Keith A. Goldan
Chief Financial Officer
Recent News
2025-12-27
Company data provided by crunchbase